GE HealthCare Technologies (NASDAQ:GEHC) Upgraded at Zacks Research

Zacks Research upgraded shares of GE HealthCare Technologies (NASDAQ:GEHC) from a hold rating to a strong-buy rating in a research note released on Thursday morning,Zacks.com reports.

Several other brokerages have also recently weighed in on GEHC. BTIG Research reissued a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Morgan Stanley lowered their price target on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an “equal weight” rating on the stock in a research report on Thursday, July 31st. Evercore ISI lowered their price target on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an “outperform” rating on the stock in a research report on Thursday, May 1st. Wall Street Zen raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 31st. Finally, Wells Fargo & Company decreased their target price on shares of GE HealthCare Technologies from $103.00 to $89.00 and set an “overweight” rating on the stock in a research report on Thursday, May 1st. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $88.55.

GE HealthCare Technologies Trading Up 0.0%

Shares of GEHC stock opened at $73.73 on Thursday. The company’s 50-day moving average price is $74.23 and its 200-day moving average price is $74.68. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The stock has a market cap of $33.66 billion, a price-to-earnings ratio of 15.11, a PEG ratio of 2.82 and a beta of 1.13. GE HealthCare Technologies has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.15. The firm had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company’s revenue was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities analysts predict that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were given a $0.035 dividend. The ex-dividend date of this dividend was Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 2.87%.

Institutional Trading of GE HealthCare Technologies

Hedge funds have recently made changes to their positions in the business. N.E.W. Advisory Services LLC acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth about $25,000. Bogart Wealth LLC lifted its position in shares of GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after purchasing an additional 247 shares in the last quarter. Allianz SE lifted its position in shares of GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after purchasing an additional 218 shares in the last quarter. Stonebridge Financial Group LLC increased its stake in shares of GE HealthCare Technologies by 165.7% during the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock worth $29,000 after buying an additional 222 shares during the period. Finally, Accredited Wealth Management LLC purchased a new stake in shares of GE HealthCare Technologies during the fourth quarter worth approximately $30,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.